[
  {
    "ts": null,
    "headline": "Inflation Data, Intel and Tesla Earnings: What to Watch Next Week",
    "summary": "The U.S. government shutdown is set to drag into another week, but that doesn’t mean investors will be starved for economic data. Next Friday brings a (delayed) look at September’s consumer-price index, a key inflation reading that will factor into the Federal Reserve’s next decision on interest rates.",
    "url": "https://finnhub.io/api/news?id=302fffc394e1d75dcc2acefe27c16e7eb19bb87eb9c471cadc7b89553b9e2394",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760726478,
      "headline": "Inflation Data, Intel and Tesla Earnings: What to Watch Next Week",
      "id": 137130686,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "The U.S. government shutdown is set to drag into another week, but that doesn’t mean investors will be starved for economic data. Next Friday brings a (delayed) look at September’s consumer-price index, a key inflation reading that will factor into the Federal Reserve’s next decision on interest rates.",
      "url": "https://finnhub.io/api/news?id=302fffc394e1d75dcc2acefe27c16e7eb19bb87eb9c471cadc7b89553b9e2394"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Corp. stock outperforms competitors on strong trading day",
    "summary": "Boston Scientific Corp. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=9a04d1058063cc23f1af7c11e066d5245d213ea8f5ead8b542f9341e47cdcf28",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760718960,
      "headline": "Boston Scientific Corp. stock outperforms competitors on strong trading day",
      "id": 137139223,
      "image": "",
      "related": "BSX",
      "source": "MarketWatch",
      "summary": "Boston Scientific Corp. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=9a04d1058063cc23f1af7c11e066d5245d213ea8f5ead8b542f9341e47cdcf28"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific acquires Nalu Medical for $533m",
    "summary": "Nalu’s PNS system complements Boston’s existing neuromodulation portfolio, which includes its WaveWriter Alpha SCS system for chronic spinal pain.",
    "url": "https://finnhub.io/api/news?id=0cb023f94bbfd11dc1744ae754c475b4dc045e6fca7bea0036c09e10fa4e2dde",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760718135,
      "headline": "Boston Scientific acquires Nalu Medical for $533m",
      "id": 137127619,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Nalu’s PNS system complements Boston’s existing neuromodulation portfolio, which includes its WaveWriter Alpha SCS system for chronic spinal pain.",
      "url": "https://finnhub.io/api/news?id=0cb023f94bbfd11dc1744ae754c475b4dc045e6fca7bea0036c09e10fa4e2dde"
    }
  },
  {
    "ts": null,
    "headline": "Unlocking Q3 Potential of Boston Scientific (BSX): Exploring Wall Street Estimates for Key Metrics",
    "summary": "Besides Wall Street's top-and-bottom-line estimates for Boston Scientific (BSX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.",
    "url": "https://finnhub.io/api/news?id=203731a24f1cd6b15ef1586f9540911b3292076a621d0540ab2e6f551ee40505",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760706904,
      "headline": "Unlocking Q3 Potential of Boston Scientific (BSX): Exploring Wall Street Estimates for Key Metrics",
      "id": 137125856,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Besides Wall Street's top-and-bottom-line estimates for Boston Scientific (BSX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.",
      "url": "https://finnhub.io/api/news?id=203731a24f1cd6b15ef1586f9540911b3292076a621d0540ab2e6f551ee40505"
    }
  },
  {
    "ts": null,
    "headline": "Intuitive Surgical Pre-Q3 Analysis: Buy, Hold or Sell ISRG Stock Now?",
    "summary": "Intuitive Surgical enters Q3 earnings season on strong momentum, backed by robust procedure growth and da Vinci 5 adoption. However, tariff risks and global CapEx constraints remain challenges.",
    "url": "https://finnhub.io/api/news?id=0df0f03705a7af5982f3c39144f0d3a9b9e0c43beb285e3bd7a7385752ebf734",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760706540,
      "headline": "Intuitive Surgical Pre-Q3 Analysis: Buy, Hold or Sell ISRG Stock Now?",
      "id": 137125783,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Intuitive Surgical enters Q3 earnings season on strong momentum, backed by robust procedure growth and da Vinci 5 adoption. However, tariff risks and global CapEx constraints remain challenges.",
      "url": "https://finnhub.io/api/news?id=0df0f03705a7af5982f3c39144f0d3a9b9e0c43beb285e3bd7a7385752ebf734"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific to buy Nalu Medical for $533M",
    "summary": "Nalu’s implantable neurostimulation system delivers electrical impulses to treat chronic pain originating from the peripheral nerves.",
    "url": "https://finnhub.io/api/news?id=1bf81a44b0331b2344f3f98ecb29dc0b929072080354bac0b37d5fd243e0cb93",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760698831,
      "headline": "Boston Scientific to buy Nalu Medical for $533M",
      "id": 137127621,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Nalu’s implantable neurostimulation system delivers electrical impulses to treat chronic pain originating from the peripheral nerves.",
      "url": "https://finnhub.io/api/news?id=1bf81a44b0331b2344f3f98ecb29dc0b929072080354bac0b37d5fd243e0cb93"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Announces Agreement to Acquire Nalu Medical, Inc.",
    "summary": "Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Nalu Medical, Inc., a privately held medical technology company focused on developing and commercializing innovative and minimally invasive solutions for patients with chronic pain.",
    "url": "https://finnhub.io/api/news?id=0af0a5ccbb6398950da3eb74f5919e71c3c19656574a13aa29ac99f7eee9b652",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760698800,
      "headline": "Boston Scientific Announces Agreement to Acquire Nalu Medical, Inc.",
      "id": 137125858,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Nalu Medical, Inc., a privately held medical technology company focused on developing and commercializing innovative and minimally invasive solutions for patients with chronic pain.",
      "url": "https://finnhub.io/api/news?id=0af0a5ccbb6398950da3eb74f5919e71c3c19656574a13aa29ac99f7eee9b652"
    }
  }
]